Cargando…
74. Empiric Antibiotic Therapy and Community-onset Bacterial Co-infection in Patients Hospitalized with COVID-19: A Multi-hospital Cohort Study
BACKGROUND: Antibiotic therapy has no known benefit against COVID-19, but is often initiated out of concern for concomitant bacterial infection. We sought to determine how common early empiric antibiotic therapy and community-onset bacterial co-infections are in hospitalized patients with COVID-19....
Autores principales: | Vaughn, Valerie, Gandhi, Tejal N, Petty, Lindsay A, Patel, Payal K, Prescott, Hallie, Malani, Anurag N, Ratz, David, McLaughlin, Elizabeth, Chopra, Vineet, Flanders, Scott A |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Oxford University Press
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7777828/ http://dx.doi.org/10.1093/ofid/ofaa439.384 |
Ejemplares similares
-
Empiric Antibacterial Therapy and Community-onset Bacterial Coinfection in Patients Hospitalized With Coronavirus Disease 2019 (COVID-19): A Multi-hospital Cohort Study
por: Vaughn, Valerie M, et al.
Publicado: (2020) -
Variation in COVID-19 characteristics, treatment and outcomes in Michigan: an observational study in 32 hospitals
por: Chopra, Vineet, et al.
Publicado: (2021) -
Three-day antibiotic duration in patients with pneumonia: A sixty-eight–hospital cohort
por: Vaughn, Valerie, et al.
Publicado: (2023) -
Risk Factors and outcomes associated with inappropriate empiric broad-spectrum antibiotic use in hospitalized patients with community-acquired pneumonia
por: Gandhi, Tejal, et al.
Publicado: (2023) -
Antibiotic Overuse After Hospital Discharge: A Multi-hospital Cohort Study
por: Vaughn, Valerie M, et al.
Publicado: (2020)